SCHEMBL23309490

SCHEMBL23309490

O=C(Nc1ccccc1)c1cc(F)nc(F)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.51
▸ MEN1 O00255 6/20 0.49
▸ KMT2A Q03164 6/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ HTT P42858 3/20 0.48
▸ USP2 O75604 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ TDP1 Q9NUW8 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ METAP2 P50579 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309730 0.92 KMT2A (0.47) GAAMEN1KMT2ANPC1RAB9A
SCHEMBL23309562 0.88 PNLIP (0.56) GAAMEN1KMT2ANPC1RAB9A
SCHEMBL23309555 0.86 HTT (0.55) NPC1RAB9AHTTL3MBTL1KDM4E
SCHEMBL23309585 0.86 KDM4E (0.52) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL23309578 0.86 BCL2 (0.44) GAAMEN1KMT2ANPC1RAB9A
SCHEMBL23309708 0.85 RAB9A (0.52) GAAKMT2ANPC1RAB9AALDH1A1
SCHEMBL23309621 0.85 RAB9A (0.50) GAAMEN1KMT2ANPC1RAB9A
SCHEMBL23309536 0.84 MEN1 (0.55) GAAMEN1KMT2ANPC1RAB9A
SCHEMBL23309519 0.84 CYP11B2 (0.63) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL23309548 0.84 FADS1 (0.55) GAAMEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL GAA 75/4885MEN1 1633/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback